PATENT CLAIM ANALYSIS

Application Number: 15933596
Application Type: Utility
Filing Date: 2018-03
Publication Date: 2018-08
Patent Classification: ["424", "198100"]

Abstract:
A pharmaceutical composition and method for treating or attenuating a mood or stress-related disorder in a subject having normal or low inflammatory state is provided. In some embodiments, the pharmaceutical composition and method of the invention comprise activating or stimulating microglia for treatment of mood or stress-related disorder.

Claim (Index 3):
The method of  claim 1 , comprising the step of detecting an inflammatory state of said subject by determining Erythrocyte Sedimentation Rate (ESR), wherein an ESR level of less than 6.3 mm/h, indicates the subject has an inflammatory state suitable for treatment by the CX3CR1 inhibitor.

Metadata:
- Claim Count in Document: 9.0
- Percentile: 90.0
- Lexical Diversity: 1.45714
- Patent Class: 424.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['14913453', '15543914', '13581646', '12328625', '15110004']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.6618563157124296
- 35 USC 102 Novelty (BERT): 0.4977095288845532
- Combined Prediction Score: 0.6454416370296421
- Mean Citation Score: 196.11846
- Max Citation Score: 278.7317
- Similarity Product: 268.3659781392217

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test